Mather Group LLC. Has $1.80 Million Position in Axon Enterprise, Inc (NASDAQ:AXON)

Mather Group LLC. boosted its stake in Axon Enterprise, Inc (NASDAQ:AXON - Free Report) by 336.4% in the first quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 3,430 shares of the biotechnology company's stock after buying an additional 2,644 shares during the period. Mather Group LLC.'s holdings in Axon Enterprise were worth $1,804,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Kentucky Retirement Systems Insurance Trust Fund bought a new position in Axon Enterprise in the 1st quarter valued at about $1,110,000. CX Institutional bought a new position in shares of Axon Enterprise during the 1st quarter valued at about $115,000. GAMMA Investing LLC boosted its position in shares of Axon Enterprise by 11.8% during the 1st quarter. GAMMA Investing LLC now owns 1,454 shares of the biotechnology company's stock valued at $765,000 after purchasing an additional 154 shares in the last quarter. Blue Trust Inc. boosted its position in shares of Axon Enterprise by 33.1% during the 1st quarter. Blue Trust Inc. now owns 169 shares of the biotechnology company's stock valued at $89,000 after purchasing an additional 42 shares in the last quarter. Finally, Xponance Inc. boosted its position in shares of Axon Enterprise by 3.5% during the 4th quarter. Xponance Inc. now owns 16,469 shares of the biotechnology company's stock valued at $9,788,000 after purchasing an additional 560 shares in the last quarter. Institutional investors own 79.08% of the company's stock.

Insiders Place Their Bets

In other Axon Enterprise news, CAO Jennifer H. Mak sold 75 shares of Axon Enterprise stock in a transaction on Friday, June 13th. The shares were sold at an average price of $771.81, for a total transaction of $57,885.75. Following the sale, the chief accounting officer owned 15,240 shares in the company, valued at $11,762,384.40. The trade was a 0.49% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, Director Michael Garnreiter sold 5,913 shares of Axon Enterprise stock in a transaction on Wednesday, June 4th. The stock was sold at an average price of $760.00, for a total transaction of $4,493,880.00. Following the sale, the director owned 17,740 shares in the company, valued at $13,482,400. This represents a 25.00% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 44,642 shares of company stock valued at $30,500,428 in the last 90 days. 4.40% of the stock is currently owned by corporate insiders.

Axon Enterprise Stock Performance

AXON stock traded up $20.93 during midday trading on Friday, hitting $795.48. 268,670 shares of the company traded hands, compared to its average volume of 540,118. The business has a 50 day simple moving average of $736.97 and a 200-day simple moving average of $635.97. The stock has a market capitalization of $61.93 billion, a price-to-earnings ratio of 192.14, a price-to-earnings-growth ratio of 91.57 and a beta of 1.29. The company has a quick ratio of 2.62, a current ratio of 2.83 and a debt-to-equity ratio of 0.68. Axon Enterprise, Inc has a twelve month low of $279.02 and a twelve month high of $830.21.

Axon Enterprise (NASDAQ:AXON - Get Free Report) last announced its quarterly earnings data on Wednesday, May 7th. The biotechnology company reported $1.41 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.34 by $0.07. The business had revenue of $603.63 million for the quarter, compared to the consensus estimate of $585.67 million. Axon Enterprise had a net margin of 14.86% and a return on equity of 5.81%. Axon Enterprise's quarterly revenue was up 31.3% on a year-over-year basis. During the same quarter last year, the company posted $1.15 earnings per share. As a group, equities research analysts predict that Axon Enterprise, Inc will post 5.8 earnings per share for the current year.

Analyst Ratings Changes

Several brokerages have commented on AXON. Bank of America raised their target price on shares of Axon Enterprise from $750.00 to $895.00 and gave the stock a "buy" rating in a report on Wednesday, June 4th. Craig Hallum lowered shares of Axon Enterprise from a "buy" rating to a "cautious" rating in a research report on Monday, March 10th. The Goldman Sachs Group raised their price objective on shares of Axon Enterprise from $730.00 to $830.00 and gave the company a "buy" rating in a research report on Wednesday, May 14th. Needham & Company LLC raised their price objective on shares of Axon Enterprise from $600.00 to $750.00 and gave the company a "buy" rating in a research report on Thursday, May 8th. Finally, Barclays raised their price objective on shares of Axon Enterprise from $726.00 to $735.00 and gave the company an "overweight" rating in a research report on Friday, May 9th. One investment analyst has rated the stock with a sell rating, one has given a hold rating and ten have given a buy rating to the company. According to MarketBeat, Axon Enterprise presently has an average rating of "Moderate Buy" and an average price target of $699.55.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.